Changes in Beneficial Ownership · 4
Edesa Biotech, Inc.
EDSANASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-09-01
- Issuer
- Edesa Biotech, Inc.
- Issuer CIK
- 0001540159
- Trading symbol
- EDSA
Reporting owner 1
- Name
- Nijhawan Pardeep
- Reporting owner CIK
- 0001777962
- Relationship
- Director · Officer · 10% owner
- Officer title
- Chief Executive Officer
- Address
- C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA, A6, L3R 5H6
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | 2026-09-01 | A · Form 4 | 5,714[F1] | A | 0[F1] | 899,100 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Common Shares | 402,702 | I | Held by Pardeep Nijhawan Medicine Professional Corporation[F2] |
| Common Shares | 32,609 | I | Held by The New Nijhawan Family Trust 2015[F3] |
| Common Shares | 32,013 | I | Held by The Digestive Health Clinic Inc.[F2] |
| Common Shares | 53,104 | I | Held by 1968160Ontario Inc.[F2] |
Table key
- I
- Indirect
Footnotes
- F1
- Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.↩ 1↩ 2
- F2
- Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.↩ 1↩ 2↩ 3
- F3
- Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.↩ 1
Signature 1
- Signed
- /s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan
- Date
- 2026-09-01
Company context
Current securities
Historical securities (1)
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 23, 2026
- Other EventsOct 15, 2026
- SCHEDULE 13D/A - filed by Nijhawan Pardeep regarding Edesa Biotech, Inc.Aug 25, 2026
- SCHEDULE 13D/A - filed by Velan Capital Investment Management LP regarding Edesa Biotech, Inc.Aug 25, 2026
- Entry into a Material Definitive Agreement · Other EventsAug 20, 2026